Trials / Suspended
SuspendedNCT04057391
Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- QT Ultrasound LLC · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study aims to characterize patient experience, satisfaction and preference for use of the QT Scanner in comparison to mammography by directly engaging women who have experience with both technologies.
Detailed description
The objectives will be addressed by first conducting structured one-on-one interviews with about 20 women (Qualitative Phase), and then administering a web-based patient survey with quantitative measurements in about 200 women (Quantitative Phase). The current Protocol registration pertains to the first, qualitative phase of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | QT Scanner | Diagnostic test that is repeatable, non-invasive imaging tool for the early and accurate detection of breast cancer, breast abnormalities, and musculoskeletal findings. Comparing with mammography, the QT Scanner uses harmless soundwaves to screen and diagnose the breast. |
Timeline
- Start date
- 2019-08-06
- Primary completion
- 2019-08-30
- Completion
- 2022-12-30
- First posted
- 2019-08-15
- Last updated
- 2022-04-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04057391. Inclusion in this directory is not an endorsement.